Cover Image

Carbapenem Combinations for Infections Caused by Carbapenemase-Producing <i>Pseudomonas aeruginosa</i>: Experimental In Vitro and In Vivo Analysis

In the context of difficult-to-treat carbapenem-resistant <i>Pseudomonas aeruginosa</i> infections, we evaluated imipenem, meropenem, and doripenem combinations against eleven carbapenemase-producing <i>P. aeruginosa</i> isolates. According to the widespread global distributi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Soraya Herrera-Espejo (Author), Ester Del Barrio-Tofiño (Author), Tania Cebrero-Cangueiro (Author), Carla López-Causapé (Author), Rocío Álvarez-Marín (Author), José Miguel Cisneros (Author), Jerónimo Pachón (Author), Antonio Oliver (Author), María Eugenia Pachón-Ibáñez (Author)
Format:	Book
Published:	MDPI AG, 2022-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

In Vitro Activity of Pentamidine Alone and in Combination with Antibiotics against Multidrug-Resistant Clinical <i>Pseudomonas aeruginosa</i> Strains
by: Soraya Herrera-Espejo, et al.
Published: (2020)

Efficacy of Tamoxifen Metabolites in Combination with Colistin and Tigecycline in Experimental Murine Models of <i>Escherichia coli</i> and <i>Acinetobacter baumannii</i>
by: Soraya Herrera-Espejo, et al.
Published: (2024)

Retrospective Data Insight into the Global Distribution of Carbapenemase-Producing <i>Pseudomonas aeruginosa</i>
by: Min-Ge Wang, et al.
Published: (2021)

Development and Application of a Pragmatic Algorithm to Guide Definitive Carbapenemase Testing to Identify Carbapenemase-Producing <i>Pseudomonas aeruginosa</i>
by: Christian M. Gill, et al.
Published: (2020)

<i>Pseudomonas aeruginosa</i> Susceptibility in Spain: Antimicrobial Activity and Resistance Suppression Evaluation by PK/PD Analysis
by: Ana Valero, et al.
Published: (2021)

Clinical Significance of Carbapenem-Tolerant <i>Pseudomonas aeruginosa</i> Isolated in the Respiratory Tract
by: Momoyo Azuma, et al.
Published: (2020)

Role of the multi-drug efflux systems on the baseline susceptibility to ceftazidime/avibactam and ceftolozane/tazobactam in clinical isolates of non-carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa
by: María José Contreras-Gómez, et al.
Published: (2022)

Replacement of the Double Meropenem Disc Test with a Lateral Flow Assay for the Detection of Carbapenemase-Producing Enterobacterales and <i>Pseudomonas aeruginosa</i> in Clinical Laboratory Practice
by: Areti Tychala, et al.
Published: (2023)

Assessing the Influence of Urine pH on the Efficacy of Ciprofloxacin and Fosfomycin in Immunocompetent and Immunocompromised Murine Models of <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> Infection in the Lower Urinary Tract
by: Soraya Herrera-Espejo, et al.
Published: (2024)

Susceptibility of Meropenem-Resistant and/or Carbapenemase-Producing Clinical Isolates of <i>Enterobacterales</i> (<i>Enterobacteriaceae</i>) and <i>Pseudomonas aeruginosa</i> to Ceftazidime-Avibactam and Ceftolozane-Tazobactam as Assessed by In Vitro Testing Methods
by: Venere Cortazzo, et al.
Published: (2022)

Correlation between Carbapenem Consumption and Carbapenems Susceptibility Profiles of <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i> in an Academic Medical Center in Thailand
by: Taniya Paiboonvong, et al.
Published: (2022)

Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Strains-Distribution of the Essential Enzymatic Virulence Factors Genes
by: Tomasz Bogiel, et al.
Published: (2020)

Emerge of NDM-1-Producing Multidrug-Resistant Pseudomonas aeruginosa and Co-Harboring of Carbapenemase Genes in South of Iran
by: Ahmad FARAJZADEH SHEIKH, et al.
Published: (2020)

Characterisation of Non-Carbapenemase-Producing Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Based on Their Clinical and Molecular Profile in Malaysia
by: Yee Qing Lee, et al.
Published: (2022)

Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>
by: Worapong Nasomsong, et al.
Published: (2022)

Carbapenem-Resistant but Cephalosporin-Susceptible <i>Pseudomonas aeruginosa</i> in Urinary Tract Infections: Opportunity for Colistin Sparing
by: Márió Gajdács
Published: (2020)

Molecular Characterization of Carbapenemase Producing Acinetobacter Baumannii and Pseudomonas aeruginosa from Tertiary Care Hospitals in Mecca - Saudi Arabia
by: A Alhumaidy, et al.
Published: (2020)

Epidemiological Characteristics of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae Colonization
by: Ihn Sook Jeong, et al.
Published: (2022)

Comparison between Colistin and Polymyxin B in the Treatment of Bloodstream Infections Caused by Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii-calcoaceticus Complex</i>
by: Rebeca Carvalho Lacerda Garcia, et al.
Published: (2023)

Incidence of metallo-beta-lactamase-producing <i> Pseudomonas aeruginosa</i> in diabetes and cancer patients
by: Varaiya Ami, et al.
Published: (2008)

Molecular Analysis of Carbapenem and Aminoglycoside Resistance Genes in Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Clinical Strains: A Challenge for Tertiary Care Hospitals
by: Aamir Jamal Gondal, et al.
Published: (2024)

<i>Pseudomonas aeruginosa</i> Coharboring <i>Bla</i><sub>KPC-2</sub> and <i>Bla</i><sub>VIM-2</sub> Carbapenemase Genes
by: Tatiana Pacheco, et al.
Published: (2019)

Rapid Reversal of Carbapenemase-Producing <i>Pseudomonas aeruginosa</i> Epidemiology from <i>bla</i><sub>VIM</sub>- to <i>bla</i><sub>NDM</sub>-harbouring Isolates in a Greek Tertiary Care Hospital
by: Efthymia Protonotariou, et al.
Published: (2024)

<i>Pseudomonas aeruginosa</i> Biofilm Formation, Infections and Treatments
Published: (2021)

First report of Klebsiella pneumonia carbapenemase-producing Pseudomonas aeruginosa isolated from burn patients in Iran: phenotypic and genotypic methods
by: Lari, Abdolaziz Rastegar, et al.
Published: (2014)

Evaluation of Three Carbapenemase-Phenotypic Detection Methods and Emergence of Diverse VIM and GES Variants among <i>Pseudomonas aeruginosa</i> Isolates in Tunisia
by: Sana Ferjani, et al.
Published: (2022)

Bloodstream Infections Due to Wild-Type <i>Pseudomonas aeruginosa</i>: Carbapenems and Ceftazidime/Avibactam Prescription Rate and Impact on Outcomes
by: Carlo Pallotto, et al.
Published: (2024)

Imported PER-1 producing <it>Pseudomonas aeruginosa</it>, PER-1 producing <it>Acinetobacter baumanii </it>and VIM-2-producing <it>Pseudomonas aeruginosa </it>strains in Hungary
by: Nagy Károly, et al.
Published: (2008)

Adsorption of Phenazines Produced by <i>Pseudomonas aeruginosa</i> Using AST-120 Decreases Pyocyanin-Associated Cytotoxicity
by: Hidetada Hirakawa, et al.
Published: (2021)

In Vivo Pharmacodynamics of β-Lactams/Nacubactam against Carbapenem-Resistant and/or Carbapenemase-Producing <i>Enterobacter cloacae</i> and <i>Klebsiella pneumoniae</i> in Murine Pneumonia Model
by: Mao Hagihara, et al.
Published: (2021)

Treatment Heterogeneity in <i>Pseudomonas aeruginosa</i> Pneumonia
by: Aisling R. Caffrey, et al.
Published: (2022)

Genomic Analysis of Ceftazidime/Avibactam-Resistant GES-Producing Sequence Type 235 <i>Pseudomonas aeruginosa</i> Isolates
by: Raúl Recio, et al.
Published: (2022)

Carbapenem-Only Combination Therapy against Multi-Drug Resistant <i>Pseudomonas aeruginosa</i>: Assessment of In Vitro and In Vivo Efficacy and Mode of Action
by: Brendan Mackay, et al.
Published: (2022)

Insights into the Rising Threat of Carbapenem-Resistant Enterobacterales and <i>Pseudomonas aeruginosa</i> Epidemic Infections in Eastern Europe: A Systematic Literature Review
by: Michal Piotrowski, et al.
Published: (2024)

Comparison of Different Methods for Assaying the In Vitro Activity of Cefiderocol against Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Strains: Influence of Bacterial Inoculum
by: Celia García-Rivera, et al.
Published: (2024)

Detection of OXA-181-producing Pseudomonas aeruginosa in Germany
by: Jennifer Schauer, et al.
Published: (2022)

Prevalence of Carbapenemases in Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates from the Kingdom of Bahrain
by: Nouf Al-Rashed, et al.
Published: (2023)

Antimicrobial Treatment of <i>Pseudomonas aeruginosa</i> Severe Sepsis
by: Johnny Zakhour, et al.
Published: (2022)

The Basis for Natural Multiresistance to Phage in <i>Pseudomonas aeruginosa</i>
by: Christine Pourcel, et al.
Published: (2020)

Survey of VA Laboratory Practices for Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
by: Aubrey Sawyer, et al.
Published: (2024)